Some of Friday's midday movers:» Read More
American Express reported second-quarter earnings of 88 cents a share, topping estimates, though revenue came in short of expectations.
The Dow Jones Industrial Average closed at a record high, but slipped below 14,000 after trading above the milestone earlier in the session. Traders remained optimistic that the market will power higher. "We're not going to stop at 14,000; it's just an arbitrary number," said Gordon Charlop, president of Walter J. Dowd.
Tomorrow, the NBC Universal Family brings us Live Earth--with a three hour primetime special on NBC, plus 18 hours of coverage of Bravo and seven hours on our very own CNBC. Plus coverage on all sorts of other channels in the family--including Telemundo, Mun2, Universal HD, and the Sundance Channel. A sign of the power of the Live Earth message, NBC has attracted some top-notch (huge and influential) advertisers--General Motors, Apple, and American Express.
On Wall Street, the Berkshire Hathaway chief is a god. But does he still have his mojo after all these years?Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
Pharmaceutical stocks is the place to invest in the current market, according to Kris Jenner, portfolio manager for the T. Rowe Price Health Sciences Fund. The medical doctor told "Morning Call" viewers he likes large-cap Wyeth and small-cap Alexion Pharmaceuticals, in particular. "There is no more valuable opportunity in the pharmaceutical industry today than bringing forward an Alzheimer's product," Jenner said of Wyeth, which has made advances in treating the disease.
New York-based credit card and travel services company American Express is expected to sell its private banking business within weeks, said a source familiar with the matter.
In a first for the credit card industry, American Express is allowing some cardholders to charge their monthly mortgage payments.
I love plastic. I know, I know, the petroleum issues. But today I learned one more reason to love plastic: I can pay for my mortgage with it. Yes, American Express is breaking new ground, allowing its card members to pay their monthly mortgage bills on the card. I know what you're thinking, but hold on... Amex is requiring that these be prime loans only, so you can forget that whole subprime mortgage implosion issue. And of course, they'll be charging you $395 to enroll in the program.
After a recent Supreme Court ruling, this company could be in the clear. That's one more reason to own the stock.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
If the index is going to reach Cramer's target level, it's going to need some help from its components. Here are the first six and how they should push the Dow higher.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
Mergers and acquisitions dominated headlines during the week as the S&P 500 ended above 1,500 for the first time in more than seven years and came within striking distance of an all-time high of 1,527 set in March 2000. "Merger activity is one of the things that's driving the strength in this market," said Ted Weisberg, president of Seaport Securities.
The New York-based company said net income rose to $1.057 billion, or 88 cents a share, from $873 million, or 69 cents a share, in the year-ago period.
Citigroup said on Thursday Damian Kozlowski, chief executive of its private banking unit, is leaving the company, in the latest management change at the largest U.S. bank.
Hey folks. Here's the best performing trades by % gain from Friday's close to Monday's close: Biosite--If you bought on Friday at $55.38 and held/sold on Monday with a close of $83.80, the contestant gained 51.32% on the trade (9 out of the 10 current weekly leaders as of Monday's close bought BSTE on Friday).
The biggest winner of the Oscars has already started to collect. It's not a celebrity or producer, it's ABC. The network recently wrapped up its ad sales for the telecast on the 25th, grabbing more than $1.6 million per thirty-second spot, for over $80 million dollars in revenue. That's double the revenue in 1998, and up from $72 million total last year.
Stocks ended sharply lower after a day long selling spree, sparked by worries corporate earnings growth is showing signs of weakening.
American Experss said on Monday that fourth-quarter profit rose about 24% - and met analysts' forecasts - as customers of the fourth-largest credit-card issuer spent more money.
Who's the best CEO in the country? Morningstar knows what separates the best from the rest. On CNBC’s “Morning Call” Pat Dorsey, Morningstar's Director of Stock analysis revealed Morningstar’s CEO of the Year!
Stocks ended the day on the downside with more deals and earnings news driving the momentum on Wall Street today. All three major indexes closed down fractionally. The Dow Jones Industrial Average traded in a narrow range of about 40 points. More from Mary Thompson, CNBC’s “Eye on the Floor.”
The same rare, but fatal viral infection that forced Biogen Idec and Elan to recall, and recently relaunch, the multiple sclerosis drug, Tysabri, may also be a side effect of Rituxan, also from Biogen Idec and Genentech. In an SEC filing -- not a press release -- and on the FDA website, the companies and the agency disclosed yesterday evening that two people with lupus died after taking Rituxan.